Clinical Trial Update: Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure [Phase 4]

View source ↗

Summary

Phase 4 efficacy study update for Xin Ran (nifedipine controlled-release tablets) evaluating early morning blood pressure and central arterial pressure in essen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Xin Ran Nifedipine Controlled-Release Tablets (Nifedipine)

Snippet

Sponsor: Shanghai Shyndec Pharmaceutical Co., Ltd. | Conditions: Essential Hypertension | Phase 4 | Status: UNKNOWN